|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 92 No. 3 (August 1), 1998:
pp. 810-821
Clinical Significance of MLL-AF4 Fusion Transcript Expression
in the Absence of a Cytogenetically Detectable t(4;11)(q21;q23)
Chromosomal Translocation
Fatih M. Uckun,
Kim Herman-Hatten,
Mya-Lisa Crotty,
Martha G. Sensel,
Harland N. Sather,
Lisa Tuel-Ahlgren,
Mireille B. Sarquis,
Bruce Bostrom,
James B. Nachman,
Peter G. Steinherz,
Paul
S. Gaynon, and
Nyla Heerema
From the Children's Cancer Group ALL Biology Reference Laboratory,
Parker Hughes Cancer Center, and the Departments of Biology,
Immunology, and Molecular Genetics, Hughes Institute, St Paul, MN; The
Children's Cancer Group Operations Office, Arcadia, CA; the Department
of Preventive Medicine, University of Southern California School of
Medicine, Los Angeles; the Department of Medical and Molecular
Genetics, Indiana University School of Medicine, Indianapolis; the
Department of Pediatric Hematology-Oncology, Children's Health Care,
Minneapolis, MN; the Section of Pediatric Hematology-Oncology,
University of Chicago Medical Center, Chicago, IL; the Department of
Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY; and
the Department of Pediatric Hematology-Oncology, University of
Wisconsin, Madison.
Leukemic cells from bone marrow (BM) of 17 infants and 127 children
with newly diagnosed ALL, as well as fetal liver and BM and normal
infant BM samples, were analyzed for presence of a t(4;11)
translocation using standard cytogenetic techniques and expression of
an MLL-AF4 fusion transcript using standard reverse transcriptase-polymerase chain reaction (RT-PCR) assays as well as
nested RT-PCR that is 100-fold more sensitive than standard RT-PCR.
Overall, 9 of 17 infants and 17 of 127 noninfant pediatric ALL patients
were positive for expression of MLL-AF4 fusion transcripts, as
determined by standard and/or nested RT-PCR assays. None of the
MLL-AF4+ cases were positive for E2A-PBX1
or BCR-ABL fusion transcript expression. Although 8 of 9 MLL-AF4+ infants had cytogenetically detectable
t(4;11)(q21;q23), 15 of the 17 MLL-AF4+
noninfants were t(4;11) . Infants with
MLL-AF4+ ALL had poor outcomes, whereas
non-infant MLL-AF4+/t(4;11)
patients had favorable outcomes similar to
MLL-AF4 patients. Notably, MLL-AF4
transcripts also were detected by nested RT-PCR in 4 of 16 fetal BMs, 5 of 13 fetal livers, and 1 of 6 normal infant BMs, but not in any of the
44 remission BM specimens from pediatric ALL patients. Our results
provide unprecedented evidence that MLL-AF4 fusion transcripts
can be present in normal hematopoietic cells, indicating that their
expression is insufficient for leukemic transformation of normal
lymphocyte precursors.
© 1998 by The American Society of Hematology.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. S. Brassesco, A. P. Montaldi, D. E. Gras, M. L. Camparoto, N. M. Martinez-Rossi, C. A. Scrideli, L. G. Tone, and E. T. Sakamoto-Hojo
Cytogenetic and molecular analysis of MLL rearrangements in acute lymphoblastic leukaemia survivors
Mutagenesis,
March 1, 2009;
24(2):
153 - 160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Greaves, A. T. Maia, J. L. Wiemels, and A. M. Ford
Leukemia in twins: lessons in natural history
Blood,
October 1, 2003;
102(7):
2321 - 2333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P F Ravetto, R Agarwal, M L Chiswick, S W D'Souza, O B Eden, and G M Taylor
Absence of leukaemic fusion gene transcripts in preterm infants exposed to diagnostic x rays
Arch. Dis. Child. Fetal Neonatal Ed.,
May 1, 2003;
88(3):
F237 - F244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Betti, M. J. Villalobos, M. O. Diaz, and A. T. M. Vaughan
Apoptotic Stimuli Initiate MLL-AF9 Translocations that Are Transcribed in Cells Capable of Division
Cancer Res.,
March 15, 2003;
63(6):
1377 - 1381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Siraj, U. Ozbek, S. Sazawal, S. Sirma, G. Timson, A. Al-Nasser, M. Bhargava, H. El Solh, K. Bhatia, and M. I. Gutierrez
Preclinical Validation of a Monochrome Real-Time Multiplex Assay for Translocations in Childhood Acute Lymphoblastic Leukemia
Clin. Cancer Res.,
December 1, 2002;
8(12):
3832 - 3840.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Mori, S. M. Colman, Z. Xiao, A. M. Ford, L. E. Healy, C. Donaldson, J. M. Hows, C. Navarrete, and M. Greaves
Chromosome translocations and covert leukemic clones are generated during normal fetal development
PNAS,
June 11, 2002;
99(12):
8242 - 8247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. J. Weston, C. M. McConville, J. R. Mann, P. J. Darbyshire, S. Lawson, J. Gordon, P. A. H. Moss, A. Malcolm, R. Taylor, and T. Stankovic
Molecular Analysis of Single Colonies Reveals a Diverse Origin of Initial Clonal Proliferation in B-Precursor Acute Lymphoblastic Leukemia that Can Precede the t(12;21) Translocation
Cancer Res.,
December 1, 2001;
61(23):
8547 - 8553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Mrozek, T. W. Prior, C. Edwards, G. Marcucci, A. J. Carroll, P. J. Snyder, P. R.K. Koduru, K. S. Theil, M. J. Pettenati, K. J. Archer, et al.
Comparison of Cytogenetic and Molecular Genetic Detection of t(8;21) and inv(16) in a Prospective Series of Adults With De Novo Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
J. Clin. Oncol.,
May 1, 2001;
19(9):
2482 - 2492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kuwada, F. Kimura, T. Matsumura, T. Yamashita, Y. Nakamura, N. Wakimoto, T. Ikeda, K. Sato, and K. Motoyoshi
t(11;14)(q23;q24) Generates an MLL-Human Gephyrin Fusion Gene along with a de facto Truncated MLL in Acute Monoblastic Leukemia
Cancer Res.,
March 1, 2001;
61(6):
2665 - 2669.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Cimino, L. Elia, M. C. Rapanotti, T. Sprovieri, M. Mancini, A. Cuneo, C. Mecucci, G. Fioritoni, M. Carotenuto, E. Morra, et al.
A prospective study of residual-disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia
Blood,
January 1, 2000;
95(1):
96 - 101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Sun, P. A. Goodman, C. M. Wood, M.-L. Crotty, M. Sensel, H. Sather, C. Navara, J. Nachman, P. G. Steinherz, P. S. Gaynon, et al.
Expression of Aberrantly Spliced Oncogenic Ikaros Isoforms in Childhood Acute Lymphoblastic Leukemia
J. Clin. Oncol.,
December 1, 1999;
17(12):
3753 - 3766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Wiener, T. I. Kuschak, S. Ohno, and S. Mai
Deregulated expression of c-Myc in a translocation-negative plasmacytoma on extrachromosomal elements that carry IgH and myc genes
PNAS,
November 23, 1999;
96(24):
13967 - 13972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dordelmann, A. Reiter, A. Borkhardt, W.-D. Ludwig, N. Gotz, S. Viehmann, H. Gadner, H. Riehm, and M. Schrappe
Prednisone Response Is the Strongest Predictor of Treatment Outcome in Infant Acute Lymphoblastic Leukemia
Blood,
August 15, 1999;
94(4):
1209 - 1217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Reichel, E. Gillert, I. Breitenlohner, R. Repp, J. Greil, J. D. Beck, G. H. Fey, and R. Marschalek
Rapid Isolation of Chromosomal Breakpoints from Patients with t(4;11) Acute Lymphoblastic Leukemia: Implications for Basic and Clinical Research
Cancer Res.,
July 1, 1999;
59(14):
3357 - 3362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Felix and B. J. Lange
Leukemia in Infants
Oncologist,
June 1, 1999;
4(3):
225 - 240.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Trka, J. Zuna, O. Hrusak, K. Michalova, K. Muzikova, M. Kalinova, and J. Stary
No Evidence for MLL/AF4 Expression in Normal Cord Blood Samples
Blood,
February 1, 1999;
93(3):
1106 - 1107.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-H. Kim-Rouille, A. MacGregor, L.M. Wiedemann, M.F. Greaves, C. Navarrete;, and F. M. Uckun
MLL-AF4 Gene Fusions in Normal Newborns
Blood,
February 1, 1999;
93(3):
1107 - 1110.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Sun, N. Heerema, L. Crotty, X. Wu, C. Navara, A. Vassilev, M. Sensel, G. H. Reaman, and F. M. Uckun
Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia
PNAS,
January 19, 1999;
96(2):
680 - 685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. Hunger and M. L. Cleary
What Significance Should We Attribute to the Detection of MLL Fusion Transcripts?
Blood,
August 1, 1998;
92(3):
709 - 711.
[Full Text]
[PDF]
|
 |
|
|
|